纳米尺度的双相酸调节骨质生成并减轻LPS诱导的炎症
Yi-Chun Su1, Trinh T T Phan1, Tzu-Wei Wang2
1Institute of Molecular and Cellular Biology, College of Life Sciences and Medicine, National Tsing Hua University, Hsinchu, Taiwan.
Frontiers in bioengineering and biotechnology
|December 14, 2023
概括
新型双相酸盐 (BCP) 纳米材料通过促进骨质生成和调节免疫反应来增强骨愈合. 这些BCP纳米材料在临床环境中显示出治疗炎症性骨损失的潜力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 整形外科的研究研究.
背景情况:
- 微微尺度的双相酸 (BCP) 材料用于骨修复.
- 对用于骨再生的纳米级BCP材料的研究是有限的.
- 了解纳米级BCP与骨细胞和免疫细胞的相互作用至关重要.
研究的目的:
- 为了合成和表征颗粒状BCP纳米材料.
- 评估BCP纳米材料对骨质细胞活性和骨质生成的影响.
- 研究BCP纳米材料的免疫调节特性及其对炎症状况的影响.
主要方法:
- 纳米研磨分散过程使用聚合物碳酸散剂.
- 人类骨质母细胞和THP-1衍生的巨细胞培养.
- 评估性酸酶 (ALP) 活性,骨质生成相关的基因表达和炎症性基因表达.
- 评估BCP纳米材料对LPS诱导的炎症和巨受条件的介质的影响.
主要成果:
- 合成的BCP纳米材料具有负表面电荷,无细胞毒性,可以透细胞.
- BCP纳米材料显著增加了ALP活性,并在骨质母细胞中调高了骨质生成相关基因.
- BCP纳米材料减少了巨细胞中的炎症基因表达,并减轻了LPS诱导的炎症.
- BCP纳米材料逆转了LPS刺激的巨受条件介质对骨质细胞的负面影响.
结论:
- BCP纳米材料在骨组织修复和再生方面具有显著的潜力.
- BCP纳米材料的骨质生成和免疫调节特性提供了一个有前途的治疗策略.
- 进一步研究BCP纳米材料的炎症性骨质解体是必要的临床应用.
关键词:
这是一种抗炎症药物.双相材料是双相的材料.免疫调节 免疫调节 免疫调节炎症反应是一种炎症反应.巨细胞是什么?巨细胞是什么?纳米尺度的双相酸纳米材料纳米尺度的双相酸纳米材料骨质母细胞 (osteoblasts) 是一个骨质细胞.更多相关视频
07:53Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
18.1K
08:28A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
Published on: May 21, 2020
6.7K
相关概念视频
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
